BIOCRYST PHARMACEUTICALS INC — Director's Dealing 2015

Jun 24, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOCRYST PHARMACEUTICALS INC (BCRX)
CIK: 0000882796
Period of Report: 2015-06-22

Reporting Person: STAAB THOMAS R II (Senior Vice President and CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-06-22	Common Stock	M	3750	$4.73	Acquired	149894	Direct
2015-06-22	Common Stock	S	3750	$16.00	Disposed	146144	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-06-22	Emp. Stock Option (Right to Buy)	$4.73	M	3750	Disposed	2022-03-01	Common Stock (3750)	Direct

Footnotes

F1: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2014.